Print

Coronado Biosciences to Moderate Diabetes Panel at the 8th Annual Swedish-American Life Science Summit in Stockholm  
8/22/2012 9:37:36 AM

BURLINGTON, Mass., Aug. 22, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Karin Hehenberger, Executive Vice President and Chief Medical Officer, will moderate a panel on diabetes at the 8th Annual Swedish-American Life Science Summit (SALSS) on Thursday, August 23, 2012.
//-->